Skip to Main Content

Sara Rockwell, PhD, FASTRO

Professor Emeritus of Therapeutic Radiology
DownloadHi-Res Photo

Contact Info

Therapeutic Radiology

15 York Street PO Box 208040

New Haven, CT 06513

United States

About

Titles

Professor Emeritus of Therapeutic Radiology

Biography

Sara Rockwell received her B.S. in Physics in from Penn State in 1965 and her Ph.D. in Biophysics from Stanford in 1971. She received postdoctoral training as a Damon Runyon Postdoctoral Fellow at Stanford University and as an Attache de Recherche at the Institut Gustave Roussy in Villejuif, France. In 1974 she joined the faculty of the Yale University School of Medicine and is now Professor of Therapeutic Radiology and Pharmacology. Professor Rockwell taught radiation biology, pharmacology, cancer biology, ethics, and career development skills in several Yale courses and lecture series. Her laboratory research focused on studying the unphysiological microenvironments of cells within solid tumors, with the goal of improving the treatment of cancer. She was among the first researchers to study the effects of hypoxia on the response of malignant cells in culture and solid tumors in vivo to radiation, anticancer drugs, and combined modality therapy and among the first to consider the implications of the hypoxia found in microscopic tumors for the development and evolution of solid malignancies. The results of this research have been published in over 200 scientific publications and presented in over 250 papers at national and international scientific meetings. Professor Rockwell has received numerous awards for her educational and research activities, including election to membership in the Connecticut Academy of Science and Engineering and selection as a Fellow of the American Society for Radiation Oncology (ASTRO).



Professor Rockwell had served on advisory panels for the NIH, DOD, NASA, OSTP and other governmental agencies, the American Cancer Society, other voluntary health organizations, and several universities. She served a two-year term as chair of the NCI Initial Review Group for Clinical Research Studies. She was an active member of several professional societies and had served on the editorial boards of five scientific journals. She served as the Editor-in-Chief of Radiation Research, the official journal of the Radiation Research Society and the preeminent multidisciplinary journal in the radiation sciences.



Dr. Rockwell also served as the Associate Dean for Scientific Affairs for the Yale School of Medicine. She directed the Evaluation Program for the Yale Center for Clinical Investigation (Yale’s CTSA), served on the executive committee of the YCCI, and represented the YCCI on several committees of the national CTSA network. She was also the Medical School’s representative to the Association of American Medical Colleges (AAMC) Group on Research and Development. In addition, she served as Yale University’s designated Faculty Representative to the Federal Demonstration Partnership (FDP) and recently completed a term as the chair of the FDP faculty committee and vice chair of the FDP.

Appointments

Other Departments & Organizations

Education & Training

Postdoctoral Fellow
Stanford University (1974)
Attache de Recherche
Institut Gustave Roussy (1973)
Postdoctoral Fellow
Stanford University (1972)
PhD
Stanford University (1971)
BS
Penn State University

Research

Overview

Research in my laboratory examines the microenvironmental heterogeneity within solid tumors and explores the effects of these heterogeneous and often unphysiologic environments on the biology of tumor cells and of the stromal elements within solid tumors. From the time they are microscopic, solid tumors contain regions of severe hypoxia, unphysiologically low pH, and nutrient deprivation. As these tumors grow, they induce angiogenesis, but the vascular beds that develop within tumors are abnormal in both structure and function. The microenvironmental inadequacies within solid tumors have profound effects on cell physiology, altering the proliferation patterns of the cells, the metabolic pathways used by the cells, the ability of the cells to tolerate stress, DNA damage, and other injuries, and the response of the cells to radiation and to antineoplastic drugs. We are examining these alterations and studying their implication for the development and progression of solid tumors.

We are also working to develop therapeutic strategies which use our knowledge of the metabolic features of these cells improve to cancer therapy. In a collaborative project headed by Dr. Peter Glazer we are examining the effect of the adverse environments within solid tumors on gene expression, mutation rates, and DNA repair. The findings from this project suggest that the environmental stress developing within tumors early in their development may lead to the development of genomic instability and genetic heterogeneity in malignancies. One long-term project examines the metabolism, cytotoxicity, and therapeutic use of bioreductive alkylating agents which are selectively activated to toxic species by cells that are hypoxic.

Another series of studies is examining the role of nutrition and other lifestyle factors in the development, progression, and therapy of cancer. One series of studies examined the implications of subclinical vitamin A deficiency in determining the sensitivity of the lung to radiation injury and in altering the pattern of lung metastases. Another series of ongoing studies has examined the effects of the over-the-counter "alternative medicines" which are widely marketed to and used by many cancer patients. There have been very few rigorous studies examining the effects of these alternative medicines in model tumor systems or examining their interactions with conventional, effective cancer therapeutic agents to assess whether the alternative medicines may potentially be useful, ineffective, or harmful to patients being treated for cancer. Our projects address this problem.

Another project has examined the effects of PHY906, a state-of-the-art formulation of a traditional Chinese herbal medicine, on the intestinal injury induced by radiation, to assess whether PHY906 could be useful in reducing the toxic side effects of pelvic or abdominal radiotherapy.

Ethics of Peer Review: A Guide for Manuscript Reviewers. This web-based course was written for the NIH Office of Research Integrity and is freely available for use in courses on Ethical Issues in Research. The course consists of four elements:

1. Ethics of Peer Review: A Guide for Manuscript Reviewers. (https://medicine.yale.edu/therapeuticradiology/Images/Ethical_Issues_in_Peer_Review_tcm307-34211.pdf) A didactic reading, with references, designed to serve as a handout for participants in the course.

2. A PowerPoint presentation (https://medicine.yale.edu/therapeuticradiology/Images/Ethics_of_Peer_Review-Overview_tcm307-34212.ppt), which can be used by the teacher to cover the material discussed in the handout.

3. A PowerPoint presentation (https://medicine.yale.edu/therapeuticradiology/Images/Ethics_of_Peer_Review-Case_studies_tcm307-34213.ppt), presenting 12 case studies illustrating various ethical issues which might arise during the review of scientific manuscripts.

4. A Guide for the Discussion Leader (https://medicine.yale.edu/therapeuticradiology/Images/Ethics_of_Peer_Review_case_studies-guide_for_discussion_leader_tcm307-34214.pdf), which discusses each case and suggests points for discussion.

Research at a Glance

Yale Co-Authors

Frequent collaborators of Sara Rockwell's published research.

Publications

2010

2009

2008

2006

2004

2001

1999

Academic Achievements & Community Involvement

  • honor

    Distinguished Alumna

  • honor

    Distinguished Service Award

  • honor

    R F Kallman Lecturer

  • honor

    Elected Fellow

  • honor

    Elected Member

Get In Touch

Contacts

Mailing Address

Therapeutic Radiology

15 York Street PO Box 208040

New Haven, CT 06513

United States